Antenatal Milk Expression in Nulliparous Pregnant People
Feasibility and Acceptability of Antenatal Breast Milk Expression-a Pilot Randomized Trial in Nulliparous Pregnant People
1 other identifier
interventional
45
1 country
1
Brief Summary
This was a pilot randomized trial to examine the feasibility and preliminary effectiveness of a structured antenatal milk expression (AME) educational intervention on breastfeeding outcomes within a sample of low-risk pregnant individuals without other children. A convenience sample of 45 participants were enrolled and randomized to either the AME intervention or a control group receiving breastfeeding educational handouts. Both groups met with study staff at 37, 38, 39, and 40 weeks gestation to receive assigned intervention. AME participants practiced AME 1-2 times/day and recorded this in a diary. Data were collected from surveys, interviews, and electronic health record to 3-4 months postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2018
CompletedFirst Submitted
Initial submission to the registry
May 11, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedJune 18, 2021
June 1, 2021
1.6 years
May 11, 2021
June 9, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Proportion of individuals randomized
Number of individuals randomized divided by number of individuals screened
End date for study recruitment (approximately one year after beginning enrollment)
Proportion of participants completing study
Number of participants completing final study survey divided by number enrolled
End date for study data collection (approximately one year after beginning enrollment)
Secondary Outcomes (9)
Breastfeeding confidence
Enrollment, postpartum hospitalization: an average of 1-3 days postpartum, 1-2 weeks postpartum, 3-4 months postpartum
Perceived milk supply (single item)
During postpartum hospitalization: an average of 1-3 days postpartum, 1-2 weeks postpartum, 3-4 months postpartum
Perceived milk supply (scale score)
During postpartum hospitalization: an average of 1-3 days postpartum, 1-2 weeks postpartum, 3-4 months postpartum
In-hospital formula use
Discharge from birth hospital: an average of 1-3 days postpartum
Breastfeeding continuation
1-2 weeks postpartum, 3-4 months postpartum
- +4 more secondary outcomes
Study Arms (2)
AME Hand-Expression
EXPERIMENTALParticipants in the antenatal milk expression (AME) group will learn hand-expression from a certified lactation consultant beginning at 37 weeks of pregnancy. At the same visit, the PI or RA will also provide oral and written instructions for AME at home, specifically instructing participants to do AME 1-2 times per day for no longer than 10 minutes.
Education
ACTIVE COMPARATORParticipants in the education group will receive a weekly educational hand-out on varying breastfeeding topics (e.g., latch).
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant with a single fetus
- /7 weeks pregnant (calculated from anticipated due date)
- No other living children and no prior breastfeeding experience
- Plan to breastfeed exclusively for at least 4 months
- At least 18 years old
- Plan to deliver baby at Magee-Womens Hospital of UPMC
- Healthy (no major medical or pregnancy condition which would constitute a high-risk pregnancy)
You may not qualify if:
- Women with contraindications to breastfeeding, as specified by American Academy of Pediatrics, including HIV+ status, human T-cell lymphotrophic virus, etc. HIV status will be assessed by history (maternal self-report of diagnosis).
- Conditions known to significantly adversely impact maternal milk supply (e.g., breast hypoplasia, history of breast reduction surgery, as assessed on screening form)
- Conditions which predispose to preterm labor or otherwise constitute a high-risk pregnancy as outlined by the National Institute of Child Health and Human Development including: breech presentation, vaginal bleeding during second or third pregnancy trimester (more than one episode, not related to possible cervical mechanical trauma from sexual intercourse or cervical exam), diagnosed or suspected developmental abnormalities in the fetus, less than 6 months between last birth and the beginning of current pregnancy, placenta previa, diabetes type I or II or gestational diabetes, preeclampsia (or hypertension with proteinuria), smoking, alcohol use, or illicit drug use during pregnancy, oligohydramnios/polyhydramnios, any previous second or third trimester pregnancy loss/miscarriage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- American Nurses Foundationcollaborator
Study Sites (1)
UPMC Magee Women's Hospital
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (1)
Demirci JR, Glasser M, Himes KP, Sereika SM. Structured antenatal milk expression education for nulliparous pregnant people: results of a pilot, randomized controlled trial in the United States. Int Breastfeed J. 2022 Jul 7;17(1):50. doi: 10.1186/s13006-022-00491-8.
PMID: 35799299DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill R Demirci, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 11, 2021
First Posted
June 18, 2021
Study Start
November 21, 2016
Primary Completion
July 9, 2018
Study Completion
July 9, 2018
Last Updated
June 18, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share